Noordam, L., Kaijen, M. E., Bezemer, K., Cornelissen, R., Maat, L. A., Hoogsteden, H. C., . . . Vroman, H. (2018). Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy. Oncoimmunology.
Chicago Style CitationNoordam, Lisanne, et al. "Low-dose Cyclophosphamide Depletes Circulating Naïve and Activated Regulatory T Cells in Malignant Pleural Mesothelioma Patients Synergistically Treated With Dendritic Cell-based Immunotherapy." Oncoimmunology 2018.
Cita MLANoordam, Lisanne, et al. "Low-dose Cyclophosphamide Depletes Circulating Naïve and Activated Regulatory T Cells in Malignant Pleural Mesothelioma Patients Synergistically Treated With Dendritic Cell-based Immunotherapy." Oncoimmunology 2018.